$BBWI

Bath & Body Works, Inc. (BBWI): Results of Operations and Financial Condition

Bath & Body Works, Inc. (BBWI) filed an SEC Form 8-K — Results of Operations and Financial Condition.

Original reporting
Published Aug 26, 2026, 11:17 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 11:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$BBWI
Neutral
low confidence
Mentioned
$BBWI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BBWINeutralLow
01

Why it matters

The filing itself is the primary news; no financial details are provided, limiting trading relevance.

02

Market read

Primary disclosure of a results filing with no disclosed metrics; low immediate trading relevance.

03

What to watch

Potential upcoming guidance or management commentary not yet released.

Relevance 7/10Novelty 2/10Timing: filed today

Background

Bath & Body Works filed an 8‑K on Aug 26 2026 reporting its results of operations.

Company-level read

Ticker impact

$BBWINeutralLow confidence
Context

SEC Form 8‑K filed reporting Results of Operations and Financial Condition

Expected impact

Limited immediate impact due to lack of disclosed numbers.

Evidence & confidence

Without revenue or earnings data, traders have little actionable information.

Market effects

None disclosed; filing pertains only to Bath & Body Works.

No regional effect indicated.

Minimal; company is US‑listed consumer retailer.

Counterpoint

Without numbers, the filing could hide weaker performance.

Key entities

  • Bath & Body Works, Inc.

    US‑listed retailer (ticker BBWI) filing its quarterly results.

Related articles

$BBWIHigh

Bath & Body Works lifts annual profit forecast as digital demand offsets weak store traffic

Bath & Body Works raised its full-year profit forecast and beat Q2 estimates, driven by digital demand. Sales were $1.51B, slightly above estimates. CEO Daniel Heaf noted declining store traffic. The company expects Q3 sales to drop 2.5-5% and adjusted EPS to be 7-12 cents, below analyst expectations of 26 cents. Excluding tariff refunds, Q2 EPS was 31 cents, above estimates of 24 cents.

$BBWIMed

Why Bath and Body Works (BBWI) Stock Is Trading Up Today

Bath & Body Works (BBWI) stock rose 6.5% after Citi upgraded it to Buy, citing attractive risk/reward and Q2 EPS estimates above consensus. Citi noted potential upside from new product launches and lower costs. JPMorgan raised its price target to $24. The stock closed at $20.04. BBWI is down 3.8% YTD and 37.4% from its 52-week high.

$BBWIMed

Bath & Body Works rises as Citi upgrades stock ahead of earnings

Citi upgraded Bath & Body Works (BBWI) to Buy from Neutral ahead of its second-quarter results next week. Citi expects an earnings beat, modeling Q2 EPS of $0.26 versus $0.24 consensus and $0.20 to $0.25 guidance. Citi kept full-year 2026 estimates and its $25 price target, citing potential upside from lower energy prices and tariff refunds. Shares rose over 2% premarket.

$BBWIMed

Why is Bath & Body Works stock climbing today?

Bath & Body Works (BBWI) rose 2.9% in pre-open trading Tuesday after Citi upgraded the stock from Neutral to Buy, citing a steep post-earnings decline and a valuation opportunity. The upgrade followed a month of weakness, with BBWI down about 8.3% over the prior month. The company reports Q2 2026 results Aug. 26; analysts expect EPS near $0.21 on revenue about $1.49B.

$BBWIMed

Bath & Body Works Bets On Hilary Duff, Ulta To Reverse Its Slide

Bath & Body Works said it launched its biggest brand campaign, featuring Hilary Duff promoting a new Fruit Fusion fragrance line with four scents. The company also partnered with Ulta to sell body care and home fragrance products in 600+ Ulta stores starting later this month, and it sells the line on Amazon. Sales fell to $7.3B last year from $7.8B, and it expects further declines of 2.5% to 4.5%.